Arlene Chan

Summary

Publications

  1. doi request reprint Prevalence of excessive tearing in women with early breast cancer receiving adjuvant docetaxel-based chemotherapy
    Arlene Chan
    Curtin University and Mount Hospital, Australia
    J Clin Oncol 31:2123-7. 2013
  2. ncbi request reprint Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer
    Arlene Chan
    Mount Hospital, Curtin University, Perth, WA, Australia
    Anticancer Res 33:2657-64. 2013
  3. doi request reprint Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors
    Arlene Chan
    Mount Medical Centre, 41, 146 Mounts Bay Rd, Perth, Western Australia 6000, Australia
    Crit Rev Oncol Hematol 81:136-50. 2012
  4. doi request reprint Preoperative taxane-based chemotherapy in a standardized protocol for locally advanced breast cancer
    Arlene Chan
    Mount Hospital, Perth, Western Australia, Australia
    Asia Pac J Clin Oncol 8:62-70. 2012
  5. pmc A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease
    Arlene Chan
    Mount Hospital, Perth, WA 6000, Australia
    BMC Cancer 12:555. 2012
  6. doi request reprint Capecitabine and vinorelbine in metastatic breast cancer
    Arlene Chan
    Mount Medical Centre, Medical Oncologist, Mount Medical Centre, Perth 6000, Western Australia
    Eur J Cancer 45:2253-65. 2009
  7. doi request reprint Antiangiogenic therapy for metastatic breast cancer: current status and future directions
    Arlene Chan
    Mount Breast Group, Mount Hospital, Perth, Western Australia, Australia
    Drugs 69:167-81. 2009
  8. ncbi request reprint A pilot study of trimodality breast imaging surveillance in young women at high risk of breast cancer in Western Australia
    Christobel M Saunders
    School of Surgery, University of Western Australia, Perth, WA, Australia
    Med J Aust 191:330-3. 2009

Detail Information

Publications8

  1. doi request reprint Prevalence of excessive tearing in women with early breast cancer receiving adjuvant docetaxel-based chemotherapy
    Arlene Chan
    Curtin University and Mount Hospital, Australia
    J Clin Oncol 31:2123-7. 2013
    ..To define the incidence and impact of tearing in patients receiving adjuvant docetaxel-based chemotherapy and assess for lacrimal duct obstruction (LDO) as a causative factor...
  2. ncbi request reprint Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer
    Arlene Chan
    Mount Hospital, Curtin University, Perth, WA, Australia
    Anticancer Res 33:2657-64. 2013
    ..The aim of this international phase II trial was to determine the efficacy and safety profile of an oral chemotherapy doublet, oral vinorelbine plus capecitabine, and trastuzumab in this setting...
  3. doi request reprint Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors
    Arlene Chan
    Mount Medical Centre, 41, 146 Mounts Bay Rd, Perth, Western Australia 6000, Australia
    Crit Rev Oncol Hematol 81:136-50. 2012
    ..This can assist clinicians in prospectively managing relevant toxicities associated with these emerging regimens and thereby facilitate their safe and effective use in clinical practice...
  4. doi request reprint Preoperative taxane-based chemotherapy in a standardized protocol for locally advanced breast cancer
    Arlene Chan
    Mount Hospital, Perth, Western Australia, Australia
    Asia Pac J Clin Oncol 8:62-70. 2012
    ..We also evaluated the accuracy of magnetic resonance imaging (MRI) and positron emission tomography (PET) in predicting the extent of residual disease...
  5. pmc A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease
    Arlene Chan
    Mount Hospital, Perth, WA 6000, Australia
    BMC Cancer 12:555. 2012
    ..Several studies have demonstrated discordant HER2 status in the primary and metastatic tumour. However, rates of discordance vary considerably in published reports...
  6. doi request reprint Capecitabine and vinorelbine in metastatic breast cancer
    Arlene Chan
    Mount Medical Centre, Medical Oncologist, Mount Medical Centre, Perth 6000, Western Australia
    Eur J Cancer 45:2253-65. 2009
    ..In the absence of comparative, phase III data, retrospective analyses and cross-trial comparisons provide the only indication of the relative efficacy of these options...
  7. doi request reprint Antiangiogenic therapy for metastatic breast cancer: current status and future directions
    Arlene Chan
    Mount Breast Group, Mount Hospital, Perth, Western Australia, Australia
    Drugs 69:167-81. 2009
    ..Issues regarding the mechanisms of resistance, identifying combination regimens that result in the greatest clinical benefits and minimizing the adverse effects are areas that require further research...
  8. ncbi request reprint A pilot study of trimodality breast imaging surveillance in young women at high risk of breast cancer in Western Australia
    Christobel M Saunders
    School of Surgery, University of Western Australia, Perth, WA, Australia
    Med J Aust 191:330-3. 2009
    ....